Institutional investors hold a majority ownership of CELG through the 78.90% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended September 2016, these large investors purchased a net $10.0 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JENNISON ASSOCIATES LLC Bought 2.0 Million shares of Celgene
TWO SIGMA ADVISERS LP Bought 1.7 Million shares of Celgene
OPPENHEIMERFUNDS, INC. Bought 1.4 Million shares of Celgene